Fosfolax

Quick links to important sections

Fosfolax

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fosfolax

Property Description
Active ingredient Monosodium Phosphate, Disodium Phosphate
Form Aqueous Solution (Oral or Rectal)
Pharmacological class Saline Laxative (Osmotic Purgative)
General Purpose Bowel Cleansing / Acute Constipation Relief
Origin Synthetic Inorganic Compound

What Type of Medicine is Fosfolax and Its Primary Composition?

Fosfolax is a pharmaceutical preparation classified as a saline laxative, or osmotic purgative. This designation places it within the group of medications that achieve their effect through physical changes in the bowel rather than chemical irritation. The preparation is a synthetic, inorganic compound derived from mineral salts. Its active ingredients include Monosodium Phosphate (Sodium Dihydrogen Phosphate) and typically Disodium Phosphate, a balanced composition that is clinically recognized for its efficacy in rapidly clearing the lower gastrointestinal tract. The combined use of these two Sodium Phosphates ensures a formulation that maximizes the osmotic action for the intended therapeutic effect.

Dosage Forms and General Therapeutic Purpose

The medication is formulated as an aqueous solution, available for either oral administration or delivered as a rectal solution (enema). The core general therapeutic purpose of Fosfolax is to facilitate rapid, thorough bowel evacuation. It achieves this by creating an intense osmotic gradient, compelling the body to draw substantial amounts of water into the intestine. This influx of fluid serves to soften the entire stool mass and significantly increase its volume. This osmotic action is necessary for securing relief from acute constipation and is vital for achieving the complete bowel cleansing required before certain medical procedures.

What side effects are possible with Fosfolax?

Possible Side Effects and Safety Information

The official safety profile for Sodium Phosphate (Fosfolax) is organized to communicate both common, expected adverse reactions and rare, potentially severe systemic risks, as documented by regulatory authorities.

Adverse reactions are classified according to frequency, with common effects largely involving the gastrointestinal system, such as abdominal pain, nausea, and bloating. Rarer, very rare systemic adverse reactions documented in post-marketing surveillance include dehydration, hyperphosphataemia, hypocalcaemia, and hypersensitivity.

The most significant safety concerns listed in regulatory warnings involve the potential for severe systemic disturbances and organ injury. These serious adverse reactions include Acute Phosphate Nephropathy, a form of acute kidney injury, as well as cardiac arrhythmias and seizures resulting from severe electrolyte imbalances. These serious events have been reported with both the oral and rectal aqueous solution forms.

Official labeling identifies specific population-specific safety considerations. The risk of serious adverse events is explicitly heightened for older adults (over 55 years) and for patients with pre-existing conditions such as renal impairment or heart failure. A strict safety restriction is defined in regulatory documents: use of more than one dose in 24 hours is associated with a risk of severe harm and must be avoided. Furthermore, caution is documented when used concomitantly with certain medications, like diuretics, that can affect renal function or electrolyte levels.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for this saline laxative states that overdose is associated with severe fluid and electrolyte disturbances due to excessive absorption of sodium and phosphate. These imbalances may lead to serious, life-threatening clinical manifestations.

Documented Overdose Manifestations
Systemic Effects: Dizziness, confusion, severe weakness, muscle cramps, tetany, and irregular or pounding heartbeat.
Laboratory/Organ Effects: Hyperphosphatemia, hypocalcemia, hypovolemia (dehydration), and Acute Kidney Injury (AKI).

Serious or life-threatening outcomes documented in safety warnings include potentially fatal cardiac arrhythmias and acute renal failure (Acute Phosphate Nephropathy). Treatment is described as symptomatic and supportive, focusing on the correction of these critical electrolyte imbalances; no specific antidote is known.

Immediate Medical Action

Regulatory guidance mandates that immediate medical attention must be sought for specific severe symptoms. Individuals should call local emergency services if fainting, confusion, or breathing difficulties occur. Urgent medical consultation is required for signs of severe kidney involvement, such as a substantial decrease in the amount or frequency of urination, or unexplained swelling of the face, fingers, or lower legs.

Overdose risk is elevated in populations including the elderly, young children, and patients with pre-existing heart or kidney conditions.

Therapeutic Uses of Fosfolax

What Fosfolax Treats: Main Uses and Benefits

The medicine is commonly used to help with symptoms related to systemic imbalance, applied when symptoms create noticeable physiological strain and interfere with daily functioning. This class of medication may be part of symptomatic management in situations where patients experience episodic or fluctuating manifestations.

The therapeutic domain includes conditions presenting with symptoms that may intensify temporarily or those involving acute or disruptive episodes. Common areas of use are when short-term symptomatic assistance is needed to manage physical discomfort and functional stability becomes affected.

“It is applied across domains where additional symptomatic support is needed, assisting with the overall symptom load.”

Fosfolax supports the management of symptoms during conditions characterized by periods of heightened physiological stress and is relevant in contexts involving heightened systemic burden.

Quick Fact: Supports Management of Noticeable Physiological Strain

Fosfolax supports general well-being during symptomatic phases, which may help patients cope more steadily with symptom fluctuations.

Regulatory References

  1. NIH MedlinePlus overview on Sodium Phosphate

Eligibility and Restrictions for Use

Who Can and Cannot Use Fosfolax?

Fosfolax (Sodium Phosphate Saline Laxative) eligibility is strictly defined by regulatory guidelines to mitigate risks of severe electrolyte imbalance and organ damage.

Populations Prohibited from Use (Contraindicated)

Use is absolutely prohibited for specific groups and conditions, as stated in official labeling:

  • Children Under 2 Years of Age: Use of all sodium phosphate laxatives is contraindicated.
  • Severe Renal Impairment: Contraindicated in patients with severe acute or chronic kidney disease due to high risk of electrolyte abnormalities.
  • Gastrointestinal Conditions: Contraindicated in patients with known or suspected GI obstruction, bowel perforation, or toxic megacolon.
  • Specific Surgical History: Contraindicated in patients who have undergone gastric bypass or gastric stapling surgery.

Populations Requiring Restricted or Conditional Use

Certain groups may use the medicine only with specific caution or professional consultation:

  • Older Adults (Age 55+): Caution is advised due to increased risk of kidney injury and electrolyte issues.
  • Pregnancy and Lactation: Use is restricted (classified as FDA Pregnancy Category C); professional consultation is required before use.
  • Comorbidities: Caution is required for patients with heart failure, severe dehydration, or those on a sodium-restricted diet.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fosfolax (a sodium phosphate laxative) is subject to specific interaction constraints documented in regulatory labeling, primarily due to its high sodium content and osmotic mechanism.

Pharmacodynamic and Timing Interactions

Co-administration with other medications can result in two types of officially documented interactions:

  • Additive Risk of Renal Injury and Electrolyte Disturbance: Concomitant use with specific classes of medicines creates a pharmacodynamic interaction that increases the risk of acute renal failure and severe electrolyte abnormalities. These classes include Diuretics (Water Pills), Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin Receptor Blockers (ARBs), and Nonsteroidal Anti-inflammatory Drugs (NSAIDs).

  • Reduced Absorption of Oral Drugs: The osmotic action of Fosfolax accelerates gastrointestinal transit, which can reduce the systemic exposure and effectiveness of most other oral medications. Regulatory documents mandate a timing separation for these products, typically requiring them to be administered at least one hour before or three hours after the sodium phosphate dose.

Contraindications and Population Considerations

The most severe restriction is the formal contraindication against combining Fosfolax with any other sodium phosphate-containing laxative or enema. This prohibition is due to the documented risk of severe, sometimes fatal, electrolyte toxicity.

Interaction risks related to renal impairment are officially stated as being greater in the elderly (over 55 years) and individuals with pre-existing renal impairment when co-administering the interacting drug classes mentioned above. The high sodium load also requires specific consideration for patients on a medically controlled low-salt diet.

Mechanism of Action

Disabling the Bacterial Cell Wall Assembly Line

The primary mechanism involves irreversible covalent inhibition of the bacterial enzyme UDP-N-acetylglucosamine-enolpyruvyltransferase (MurA). This action stops the very first essential step in the peptidoglycan synthesis pathway , which is unique to bacteria, leading to a complete failure to construct a protective cell wall. This specific, lethal damage results in bacterial cell lysis (rupture) due to high internal osmotic pressure, resulting in a reduction in the population of susceptible bacteria.

️ Mechanisms of Entry and Constraint

For the drug to act, it must be actively transported into the bacterial cell using specific transporters, a requirement that determines its activity against different strains. The mechanistic activity of the drug can be constrained by the presence of bacterial inactivating enzymes (e.g., FosA) that chemically neutralize the molecule before it reaches its target, limiting the extent of the peptidoglycan blockade and its mechanistic consequence.

Dosage and Administration Information

How to Use Fosfolax: Official Administration Guidelines

Fosfolax (Sodium Phosphate) is administered according to strict, short-term guidelines outlined in official prescribing information.


Official Administration Scope

Property Official Instruction
Route of administration Oral (Liquid or Tablets) and Rectal (Aqueous Solution/Enema).
Dosing schedule Rectal Dose (Adults ge 12): approx 118 mL (1 bottle) administered rectally. Oral Liquid Dose (Adults ge 12): 1 to 1.5 tablespoons fully diluted in water. Bowel Cleansing Regimen: A split-dose schedule for tablets (e.g., total of 32 tablets), taken over two periods.
Frequency and Timing Used as a single, acute dose for occasional constipation relief, or as a single course for preparation. Administration must not exceed once per 24 hours for constipation relief.

Labeled Administration Constraints

Proper use of Fosfolax requires adherence to specific conditions defined by the label:

  • Preparation Requirements: Oral liquid forms must be fully diluted in a specified amount of water (e.g., 8 ounces) before ingestion to manage the osmotic action.
  • Hydration: Patients are instructed to maintain adequate clear liquid intake before, during, and after administration of oral forms.
  • Age-Group Rules: The adult dose is applicable to individuals 12 years and older. Pediatric dosing for the rectal enema is reduced for children 2–11 years old, and use in children under 2 years is not recommended.
  • Procedural Restrictions: The bowel cleansing regimen must not be repeated within 7 days. The rectal tip must be inserted gently, as prescribed instructions caution against forcing the enema tip.

Connection to the Overall Use Protocol:

These official instructions establish that Fosfolax is strictly administered via the oral or rectal route at fixed, non-adjustable doses. The rules mandate a short-term, single-course pattern and require specific preparatory steps, such as dilution and essential hydration, for the medicine to be used correctly.

Recent Clinical Evidence

Research evidence / Overview of studies for Fosfolax

Evidence for Bowel Cleansing Before Procedures

Fosfolax, which contains sodium phosphate, was extensively studied in Randomized Controlled Trials (RCTs) and subsequent meta-analyses in studies examining the process of bowel preparation before certain medical procedures, such as colonoscopy. Research explored the preparation in studies where other methods were also evaluated. These studies explored the evaluation criteria for mucosal visibility for the examining clinician and also monitored patient-reported experiences like tolerability and ease of use.

Studies evaluated the attainment of adequate bowel visualization quality in trial participants. Findings describe patterns where patients often reported compliance and acceptability rates, which were monitored alongside other preparation regimens in the trials. Research describes that the outcomes monitored were typically short-term, focused on the immediate success of the preparation immediately before and during the procedure itself.

Evidence for Acute or Occasional Constipation Relief

The evidence landscape for Fosfolax's use for acute or occasional constipation has distinct differences from the pre-procedure research. This area relies more heavily on Observational Studies and small-scale clinical trials that examine temporary physiological imbalance. Studies explored responses in the general adult population and have also monitored the use of the preparation in pediatric patients experiencing acute functional limitations.

Research describes that the studies monitored a rapid time interval to the first bowel movement. Findings describe patterns where the medicine was associated with rapid acute changes, and complete bowel evacuation was noted in the observed populations. Comparative evidence against other commonly used non-saline laxatives is limited.

What Remains Uncertain About the Research for Fosfolax

The vast majority of research conducted for Fosfolax was designed to assess short-term changes and acute effects. Long-term effects are not fully established in the existing evidence. Follow-up durations were limited across the research, meaning the evidence is insufficient to draw conclusions about using this preparation for managing chronic constipation or for regular, long-term use.

For older adults (typically defined as over 70) and individuals with underlying conditions affecting fluid balance, the evidence is limited. These groups were often excluded from the larger, controlled trials, influencing the scope of the evidence regarding the acute fluid and electrolyte shifts that were observed in some studies. Research contributes to the broader evidence landscape by highlighting what has been observed so far, but it does not determine whether an individual will respond similarly.

Key Studies & References

  1. Comparison of oral sodium phosphate tablets and polyethylene glycol lavage solution for colonoscopy preparation: a systematic review and meta-analysis of randomized clinical trials (Zhang et al., 2023)

Frequently Asked Questions (FAQ)

Common questions about Fosfolax (FAQ)


Q: How quickly does Fosfolax usually start to work?

A: Official product information indicates that the rectal solution typically works very rapidly, often resulting in a bowel movement within 1 to 5 minutes after use. The onset time for the oral solution may be longer, according to product information.


Q: Can Fosfolax be taken in the morning or only at night?

A: For occasional relief, the medicine is intended as a single, acute dose. Official labeling does not mandate a specific time of day for this single use, but it strictly states that administration must not exceed once per 24 hours.


Q: Does Fosfolax have any known interactions with common painkillers like ibuprofen?

A: Yes. Official product labeling indicates a documented interaction risk with the drug class known as Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which includes ibuprofen. Taking Fosfolax with these medicines is associated with an increased risk of kidney injury and electrolyte disturbance.


Q: Is Fosfolax safe to use for a long period of time?

A: Official warnings state that the medicine should not be used for more than 3 days unless specifically directed by a healthcare professional. The medicine is intended for occasional relief or short-term procedures only.


Q: What are the most common reported side effects of Fosfolax?

A: Commonly reported adverse effects documented in official safety information include gastrointestinal symptoms such as nausea, stomach pain, and bloating. For the rectal form, anal discomfort or stinging is also noted.


Q: Can the medication be crushed or mixed with food?

A: Official administration instructions for the oral liquid form strictly mandate that the medicine must be fully diluted in water as specified in the directions. Regulatory information does not provide instructions for crushing the tablet form or mixing the liquid with food.


Q: Can people who are lactose intolerant use Fosfolax?

A: The active ingredients in Fosfolax are sodium phosphate salts, which are inorganic compounds. Confirmation requires review of the specific product's official labeling (excipients section) to confirm the presence or absence of inactive ingredients like lactose.


Q: Does Fosfolax interact with alcohol?

A: Specific clinical interaction data for alcohol is not widely documented in official patient labeling. However, regulatory guidance advises informing a healthcare professional about all substances consumed.


Q: Is Fosfolax recommended for use during pregnancy or while breastfeeding?

A: Official information states that use during pregnancy or breastfeeding is restricted. Due to the potential risks, a healthcare professional must be consulted before using the product.


Q: Why is Fosfolax available only by prescription?

A: Certain oral forms used for bowel cleansing are restricted to prescription-only use. Regulatory documents describe that these forms are associated with a risk of severe harm, including acute kidney injury and serious electrolyte imbalances, if the customary dosage is not strictly followed.


Q: Can older adults use Fosfolax safely?

A: The risk of serious adverse events is explicitly heightened for older adults (over 55 years of age). Therefore, use in this population is described as requiring specific caution and review by a healthcare professional due to increased risk of fluid and electrolyte issues.


Q: Can Fosfolax be taken with multivitamins or mineral supplements?

A: Due to the osmotic action of the medicine, it can reduce the absorption and effectiveness of most other oral drugs, including vitamins and mineral supplements. Official guidance indicates that a specific timing separation between these products is necessary.


Q: Does Fosfolax cause dependency if used for a long time?

A: While less common than with stimulant laxatives, official warnings indicate that long-term or repeated use may cause dependence and eventual loss of normal bowel function. The medicine is not intended for chronic use or regular management.


Q: Is Fosfolax suitable for people who have kidney issues?

A: The medicine is described as being contraindicated (prohibited) in patients with severe renal impairment. For those with pre-existing or less severe kidney issues, use requires specific caution from a healthcare professional due to the high risk of electrolyte toxicity.


Q: What should I do if the medicine does not seem to be working after a few days?

A: Official instructions advise that if the laxative does not produce a bowel movement, or if severe symptoms are experienced, professional medical help should be sought.


Q: Are there specific age groups that cannot use Fosfolax?

A: Yes. Use is contraindicated (prohibited) in children under 2 years of age. Use in children aged 2–11 years requires a specific, reduced dose.


Q: What happens if I accidentally take more Fosfolax than usual?

A: Taking more than the recommended dose, or more than once in 24 hours, is associated with a risk of severe dehydration, dangerous electrolyte imbalance, kidney injury, and cardiac arrhythmias.


Q: Has Fosfolax been studied in children or adolescents?

A: Yes. Regulatory documents confirm that studies have been conducted and dosing has been established for use in pediatric patients (ages 2 and older) for certain indications.


Q: Is it common to feel stomach discomfort when starting Fosfolax?

A: Yes, abdominal pain, nausea, and bloating are listed as common adverse reactions in official safety information.


Q: What are the signs of a serious or rare side effect from Fosfolax?

A: Signs of serious side effects listed in official documents include weakness, decreased urination, swelling of the extremities, seizures, or irregular heartbeat.


Q: Are there specific instructions for stopping Fosfolax?

A: Instructions advise patients to stop use and seek medical help if they notice rectal bleeding or if the laxative does not produce a bowel movement.


Q: What if I experience side effects that are not listed on the official leaflets?

A: Official guidance advises contacting a healthcare professional if any unusual or unexpected problems are experienced while using the medication.


Q: Does taking Fosfolax require regular medical monitoring or blood tests?

A: For high-risk patients, such as those with existing kidney or heart conditions, regulatory documents indicate that frequent monitoring of serum electrolyte levels (calcium, sodium, phosphate) may be necessary during use.


Q: Why are certain drug combinations described as major interactions with Fosfolax?

A: Major drug interactions, such as those with diuretics or certain blood pressure medicines, are documented because they create an additive risk of serious conditions, primarily acute renal injury and severe electrolyte disturbance.


Q: Is Fosfolax habit-forming in any way?

A: Official warnings indicate that long-term or repeated use may cause dependence and loss of normal bowel function. The medicine is not intended for chronic use or regular management.


Q: What should I bring up with my doctor before starting Fosfolax?

A: Official documents list conditions that should be brought up with a healthcare professional before use, including existing conditions like kidney disease, heart problems, severe stomach pain/vomiting, or being on a sodium-restricted diet.


Q: Can Fosfolax be used for short-term relief or only long-term management?

A: The medicine is indicated only for occasional constipation relief and bowel cleansing before procedures. Use for long-term or regular management is not recommended and is associated with risk of harm, according to official warnings.


How should Fosfolax be stored and disposed of?

The official regulatory requirements for Fosfolax (Sodium Phosphate Solution/Enema) mandate specific storage and disposal protocols.


Official Storage and Disposal Statements

  • The product must be stored at Controlled Room Temperature—between 15°C and 30°C (59°F and 86°F)—and protected from excessive heat and moisture.
  • The solution must not be allowed to freeze.
  • It is mandatory to keep the medicine in its original, tightly closed container and store it out of the sight and reach of children.
  • For the single-use enema, any unused portion must be discarded immediately after administration to comply with stability constraints.
  • Disposal of expired or unused medication must follow local regulations or a community drug take-back program. The product must not be flushed down the toilet or poured into a drain unless specifically instructed by the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fosfolax found in:

A-Z Index: